Proper formation of protein phosphatase 2A (PP2A) holoenzymes is essential for the fitness of all eukaryotic cells. Carboxyl methylation of the PP2A catalytic subunit plays a critical role in regulating holoenzyme assembly; methylation is catalyzed by PP2A-specific methyltransferase LCMT-1, an enzyme required for cell survival. We determined crystal structures of human LCMT-1 in isolation and in complex with PP2A stabilized by a cofactor mimic. The structures show that the LCMT-1 active-site pocket recognizes the carboxyl terminus of PP2A, and, interestingly, the PP2A active site makes extensive contacts to LCMT-1. We demonstrated that activation of the PP2A active site stimulates methylation, suggesting a mechanism for efficient conversion of activated PP2A into substrate-specific holoenzymes, thus minimizing unregulated phosphatase activity or formation of inactive holoenzymes. A dominantnegative LCMT-1 mutant attenuates the cell cycle without causing cell death, likely by inhibiting uncontrolled phosphatase activity. Our studies suggested mechanisms of LCMT-1 in tight control of PP2A function, important for the cell cycle and cell survival.
INTRODUCTION
Protein phosphatase 2A (PP2A) is the most abundant, tightly regulated Ser/Thr phosphatase with complex composition and plays important roles in diverse aspects of cellular function in all eukaryotic cells (Virshup, 2000; Janssens and Goris, 2001 ). Several conserved proteins or enzymes regulate the phosphatase activity of PP2A by controlling the stability, activation, and inactivation of the catalytic subunit (Fellner et al., 2003; Xing et al., 2008; Kong et al., 2009 ). Substrate-specific activity of PP2A is controlled by diverse holoenzymes, comprising the scaffold A and catalytic C subunits, and a third variable regulatory B subunit from four major families: B, B 0 , B 00 , and B 000 (Virshup, 2000; Janssens and Goris, 2001 ). Formation of PP2A holoenzymes is a highly regulated process involving activation of the C subunit by PP2A phosphatase activator (PTPA) (Hombauer et al., 2007) and carboxyl methylation by leucine carboxyl methyltransferase 1 (LCMT-1) (Lee and Stock, 1993; De Baere et al., 1999) . Proper formation of PP2A holoenzymes is critical for cellular function; the malfunction of PP2A is closely linked to diverse human diseases, including cancer and Alzheimer's disease (Vafai and Stock, 2002; Sontag et al., 2004; Arroyo and Hahn, 2005; Janssens et al., 2005) . Although considerable progress had been made for understanding the atomic architectures of PP2A core enzyme and holoenzymes (Shi, 2009 ), many aspects of PP2A regulation remain unknown. Particularly, the structural basis underlying the mechanisms of activation and methylation of the C subunit remains elusive. The C subunit of PP2A possesses a flexible peptide motif at the carboxyl terminus (residues 294-309), here termed the ''PP2A tail,'' which plays an important role in regulating the oligomeric composition of PP2A complexes (Mumby, 2001) . A wealth of data support that carboxyl methylation of the last residue Leu309 of a highly conserved motif in the PP2A tail, ''T 304 PDYFL 309 ,'' enhanced the affinity of the PP2A core enzyme for the regulatory subunits (Ogris et al., 1997; Bryant et al., 1999; Tolstykh et al., 2000; Wei et al., 2001; Xing et al., 2006) . Changes in the PP2A tail and alteration of methylation also affected interaction of the C subunit with the a4 protein, which is essential for cell survival (Chung et al., 1999; Kong et al., 2004) . Several lines of evidence suggest that the PP2A-specific methyltransferase LCMT-1 is essential for cellular functions. Knockdown of LCMT-1 reduces the cellular level of PP2A methylation and induces apoptosis in mammalian cells (Lee and Pallas, 2007; Longin et al., 2007) . Loss of LCMT-1 methyltransferase activity was also linked to neurodegenerative diseases (Vafai and Stock, 2002; Sontag et al., 2004) .
Although the crystal structure of PPM1, the yeast homolog of LCMT-1, has been determined (Leulliot et al., 2004) , the molecular mechanism of LCMT-1 remains poorly understood. Many intriguing observations suggest that LCMT-1-mediated PP2A methylation might involve complex mechanisms. For example, a synthetic peptide with the conserved sequence of the PP2A tail is not a substrate of LCMT-1 (Xie and Clarke, 1994) . Okadaic acid and microcystin LR, two highly potent phosphatase inhibitor and tumor-inducing toxins, efficiently blocked PP2A methylation (Floer and Stock, 1994; Li and Damuni, 1994) . Furthermore, mutations in the PP2A active site abolished PP2A methylation in cells (Yu et al., 2001) . Atomic structures of LCMT-1 and its complex with PP2A will be critical for understanding the structural basis of these observations and the mechanism of LCMT-1 function and PP2A methylation.
Here, we report high-resolution crystal structures of LCMT-1 bound to S-adenosyl homocysteine (SAH) and in complex with the PP2A catalytic subunit. Interestingly, the structure revealed that LCMT-1 binds directly to the PP2A active site, which provides a mechanism for stimulating activated PP2A to be methylated and efficiently converted to substrate-specific holoenzymes. This suggests that LCMT-1 minimizes the unregulated phosphatase activity of the PP2A core enzyme or free C, or formation of inactive holoenzymes. A dominant-negative LCMT-1 mutant blocked the uncontrolled phosphatase activity of the core enzyme and attenuated the cell cycle without causing cell death. Our studies revealed important mechanisms of LCMT-1 in precise control of PP2A methylation and function, important for regulating the cell cycle and cell survival.
RESULTS

Structure of LCMT-1 Bound to SAH
We first determined the crystal structure of LCMT-1 in complex with SAH, the enzymatic product of cofactor S-adenosyl methionine (SAM). The complex was crystallized at 4 C. The structure was solved by molecular replacement with the model of PPM1 and was refined to a resolution of 1.9 Å (Leulliot et al., 2004) (Table 1) . The structure contains a canonical SAMdependent methyltransferase (SAM-MT) domain and a unique lid domain consisting entirely of a helices ( Figures 1A and  1B) . The MT domain comprises a central b sheet (b1-7) lying between two groups of a helices: aZ, aA, and aB on one side and aC, aD, and aE on the other side ( Figure 1B) . The lid domain is formed by three of the four unique motifs in LCMT-1 ( Figures 1A and 1B) and forms a deep active-site pocket that presumably binds to the carboxyl terminus of PP2A tail ( Figure 1C ). Alignment of structures of LCMT-1 and PPM1 revealed a key a helix, a1, within the first nonconserved unique motif (Figures S1A and S1B available online), which is located next to both the substrate and the cofactor binding pockets ( Figure 1B and Figure S1A ). Structure-based sequence alignment identified several conserved residues in a1 (Figure S1C) , including K37, which participates in cofactor binding, and T29, a catalytic residue near the sulfur atom of the X-ray diffraction data were collected on one crystal. Values in parentheses are for the highest-resolution shell.
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Structural Insights into PP2A Methylation cofactor. As shown later, T29 in a1 is an important catalytic residue.
To determine the structural basis for recognition and methylation of the PP2A tail by LCMT-1, we synthesized a peptide with the conserved sequence of the PP2A tail (RRTPDYFL). The synthetic peptide, however, failed to cocrystallize with LCMT-1, and it did not occupy the active pocket of LCMT-1 when soaked with LCMT-1 crystals, consistent with the previous observation that PP2A tail alone is not a substrate for LCMT-1 (Xie and Clarke, 1994) . To elucidate the mechanism of LCMT-1 and PP2A methylation, we went on to determine the structure of the PP2A-LCMT-1 complex.
Structure of LCMT-1 in Complex with the PP2A Catalytic Subunit The PP2A-LCMT-1 complexes are not stable and did not yield any protein crystals after extensive efforts. Reduction of the flexibility of the A subunit with the mini-A constructs that contain minimal structural elements for folding and binding to the C subunit (Xing et al., 2008) and stabilization of the enzymatic complex with the A-LCMT-1 fusion proteins failed to yield any diffracting crystals. The malleable nature of the PP2A active site and heterogeneity of the complex probably hindered crystallization. This notion is reflected by the fact that only a fraction of PP2A could be methylated in vitro (Figure 2A) , which is consistent with our later observation that methylation of the PP2A tail requires activation of the PP2A active site ( Figure 5B ). To facilitate crystallization of the PP2A-LCMT-1 complex, we synthesized a SAM mimic (Weller and Rajski, 2006 ) that became covalently bound to the PP2A tail during catalysis ( Figure 2B ). Amazingly, this reaction led to a stable PP2A-LCMT-1 complex that could be copurified by anion exchange chromatography, and separated from the fraction of PP2A that could not be methylated (data not shown). In order to obtain diffracting crystals, we introduced an internal truncation in the PP2A tail (d294-298) to the complex. The structure was solved by molecular replacement and refined to a resolution of 2.7 Å (Table 1 and Figure 2C ). This is the first structure of a complex between a methyltransferase and its substrate trapped by a SAM mimic. Note that all functional studies hereafter were performed with the full-length C subunit.
The structure of the PP2A-LCMT-1 complex reveals that the lid domain of LCMT-1 makes extensive dual contacts to both the PP2A tail and the PP2A active site ( Figures 2C and 2E ). The carboxyl-terminal six residues of the PP2A tail, ''T 304 PDYFL 309 ,'' occupy the deep active-site pocket of LCMT-1 in the lid domain ( Figure 2C ). The beginning of the PP2A tail is placed near the LCMT-1 active site, which allows the carboxyl terminus of the shortened PP2A tail to readily bind LCMT-1 (Figure 2C ). As predicted, the carboxylate group of Leu309 is covalently bound to the SAM mimic ( Figure 2D ). The extensive contacts of LCMT-1 to the PP2A active site ( Figure 2E ) indicates an important mechanism for strict control of PP2A methylation by regulation of the PP2A active site, which would suppress uncontrolled activity of the PP2A core enzyme and facilitate formation of active holoenzymes.
Mechanism of Recognition and Methylation of the PP2A Tail
The active-site pocket of LCMT-1 divides into two distinct regions: the upper entry and the deep pocket; both make extensive contacts with the PP2A tail, burying 1370 Å 2 previously exposed surface area ( Figure 3A) . The upper entry comprises helix a4 and the binding loop (BL) in the lid domain ( Figure 3B ). K62 in the BL makes key H bond interactions to D306 in the PP2A tail. F237/M241/L245 in a4 form a well-defined hydrophobic binding site for Y307 in the PP2A tail, which explains why mutations or phosphorylation of Y307 can block PP2A methylation (Yu et al., 2001; Longin et al., 2007) . The deep pocket comprises a7 in the lid domain and aZ and several b sheets in the SAM-MT domain ( Figure 3C ). Several residues from aZ and a7 make key hydrophobic contacts to F308 in the PP2A tail ( Figure 3C ).
At the bottom of the active-site pocket of LCMT-1, R73 in aZ forms bifurcated H bonds to both the cofactor and L309 in the PP2A tail ( Figure 3C ), indicating that R73 plays a role in positioning the cofactor and the PP2A tail for methyl group transfer. In addition, the side-chain hydroxyl group of T29 in a1 forms an H bond with the sulfur atom of SAH ( Figure 3C , inset), which likely stabilizes the cofactor during or after methyl group transfer. Consistent with these structural observations, mutation of R73 to alanine caused a complete loss of the methyltransferase activity, and mutation of T29 to valine dramatically decreased the methyltransferase activity of LCMT-1 ( Figure 4D ) but appeared to have a higher binding affinity to PP2A, as shown by pulldown assay and measured by isothermal titration calorimetry (ITC) (Figures 4C and 4E) . These results suggested that R73 and T29 are catalytic residues of LCMT-1. The increased binding of LCMT-1 T29V to PP2A is likely due to an enhanced hydrophobic interaction of this residue to Leu309 ( Figure 3C ). These data indicated that LCMT-1 T29V is a dominant-negative mutant; as shown later, recombinant expression of this mutant hindered the function of endogenous LCMT-1 ( Figure 6 ).
The Contacts to the PP2A Active Site Are Essential for Methylation of the PP2A Tail The rim of the lid domain in LCMT-1 makes extensive contacts to and near PP2A active-site grooves ( Figure 4A ), resulting in an interface larger than that to the PP2A tail that buries 1600 Å 2 of otherwise exposed surface area. The contacts to the PP2A active site involve several structural elements critical for the phosphatase activity and regulation of the PP2A active site. In particular, helix a7 and the loop between a6 and a7 in the lid domain interact with several C subunit loops (CLs) near the PP2A active site, including CL6, CL8, CL14, CL15, CL17, and CL19 ( Figure 4B and Table S1 ). Two conserved acidic residues in a7, D303 and E304, form a rich H bond network to the catalytic metals bridged by metal-chelated water molecules and to several residues near the PP2A active site, including R89 and R214, residues that are essential for binding PP2A substrates ( Figure 4B ). Together with R89, R268 in CL19, the longest loop near the PP2A active site, makes H bond interactions to E65 at the carboxyl terminus of the BL in LCMT-1 ( Figure 4B ). We recently determined the crystal structure of the PP2A-PTPA complex, demonstrating that R89/R214/R268 of the PP2A catalytic subunit also make key contacts to PTPA; the same PP2A active-site loops that interact with LCMT-1 bind PTPA, as well (unpublished data). Furthermore, two adjacent cysteine residues, Cys266/269, which are prone to oxidation and probably contribute to the loss of the phosphatase activity under oxidative stress (Rao and Clayton, 2002) , are buried at this interface ( Figure 4B, shaded) .
To determine whether the contacts to the PP2A active site are essential for methylation of the PP2A tail, we performed mutagenesis analysis. LCMT-1 mutations at the interface to the PP2A active site, E65R and D303R, strongly reduced PP2A binding and methylation, similar to mutations at the interface to the PP2A tail, K62E and F237D ( Figures 4C and 4D ). Mutations located outside the interface have much less effect on the methyltransferase activity of LCMT-1 ( Figure 4D ). The contacts to the PP2A active site, likely facilitate binding of the PP2A tail to LCMT-1 by increasing the binding affinity and by inducing conformational changes of the LCMT-1 active site to create the binding pocket for the PP2A tail. Alignment of all eight copies of LCMT-1 in the apoenzyme structure and LCMT-1 from the PP2A-LCMT-1 complex showed significant structural variability in helix a4 and the BL ( Figure S2A ). The apo structure that is most similar to the complex was compared in detail.
The conformation of the apo enzyme active site appears to hinder binding of the PP2A tail; the complex undergoes significant conformational rearrangement in the lid domain that allows the LCMT-1 active-site pocket to accommodate the PP2A tail ( Figure 4F ). These changes are triggered by the repulsive contacts between I240 in helix a4 and a hydrophilic surface on the edge of the PP2A active site ( Figure S2B ) and by interactions of the BL to and near the PP2A active site ( Figure S2C ). The other seven apo structures are expected to have larger difference. These structural and biochemical observations demonstrated that the contacts to the PP2A active site prime a different and better defined conformation of LCMT-1 that is essential for methylation of the PP2A tail. This explains why the synthetic peptide of the PP2A tail alone is not a substrate for LCMT-1 (Xie and Clarke, 1994) .
Precise Control of PP2A Methylation by the Phosphatase Activity The extensive contacts of LCMT-1 to a handful of critical structural elements of the PP2A active site suggest that LCMT-1 binding might be sensitive to the conformational changes of the PP2A active site. The C subunit in the PP2A-LCMT-1 complex is almost the same as in the PP2A core enzyme (Figure S3A) , indicating that LCMT-1 specifically recognizes an active conformation of PP2A. The indispensable role of these contacts for methylating the PP2A tail suggests a checkpoint for PP2A methylation that would rely on activation of the PP2A active site. The PP2A active site harbors ten flexible protein loops that participate in metal chelation ( Figure S3B ) and interaction with PTPA (Table S1 ). Due to the malleable nature of PP2A active site, we reasoned that metal binding and the ability of PTPA to sculpt an active conformation of the PP2A active site (unpublished data) would affect PP2A methylation. We recently uncovered the phenomenon that pyrophosphate (PPi) can efficiently evict PP2A catalytic metals and distort the conformation of the PP2A active site (unpublished data). Indeed, incubation of the PP2A core enzyme with PPi for 50 min abolished PP2A methylation; neither the phosphatase activity nor LCMT-1 methylation activity can be restored by the addition of Mn 2+ ( Figure 5A ). On contrary, at a molar concentration comparable to that of C, PTPA increased the methylation rate of the C subunit by 4-to 6-fold, similar in magnitude to the stimulation of the phosphatase activity toward a phosphopeptide, K-R-pT-I-R-R ( Figure 5B ). These studies demonstrated a tight link of PP2A methylation to the conformation of the PP2A active site, which explains the previous observation that mutations in the PP2A active site abolished PP2A methylation in cells (Yu et al., 2001) . Since both catalytic metals and PTPA play roles in stabilizing the active conformation of PP2A, mutations to metal-chelating residues or residues that interact with PTPA and LCMT-1 would abolish PP2A methylation both by interfering maturation of the PP2A active site and by interfering LCMT-1 binding, which agrees with previous speculations (Yu et al., 2001) .
Besides PTPA, PP2A phosphatase activity is highly regulated by a variety of cellular factors and environmental cues, such as polycations, apoptosis signals, tumor-inducing toxins, and oxidative stress (Hermann et al., 1988; Galadari et al., 1998; Rao and Clayton, 2002) . We examined the rate of PP2A methylation under these different contexts. Ceramide, the small molecule released from mitochondrion during apoptosis that was reported to stimulate the phosphatase activity of PP2A (Galadari et al., 1998) , increased the methylation rate of the C subunit in a concentration-dependent manner ( Figure 5C ). Similarly, consistent with the well-known fact that polycations stimulate PP2A phosphatase activity (Hermann et al., 1988) , a peptide with multiple positively charged residues, KRTIRR, accelerated the methylation rate of the PP2A core enzyme by LCMT-1 (Figure 5D ). These observations reflected the malleable nature of the PP2A active site and supported our notion that methylation of PP2A tail relies on activation of PP2A phosphatase activity. On contrary, PP2A methylation was blocked by inhibition and inactivation of PP2A phosphatase activity. As previously described (Floer and Stock, 1994; Li and Damuni, 1994) , tumor-inducing toxins such as okadaic acid that bind directly to the PP2A active site inhibited both the phosphatase activity and LCMT-1-mediated methylation of the PP2A core enzyme ( Figure 5E ). The two activities were also simultaneously reduced when the PP2A core enzyme was incubated with a DTT-free buffer or a buffer containing 20 mM H 2 O 2 (Figure 5E ), presumably as a result of a disulfide crosslink between Cys266 and Cys269, located near the PP2A active site and at the interface to LCMT-1. Addition of DTT to reduce the disulfide crosslink recovered both activities ( Figure 5E ).
These data demonstrated that LCMT-1-mediated PP2A methylation can function as a signaling ''hub'' that integrates a variety of signals regulating the level of PP2A phosphatase activity. This would prevent ambiguous PP2A function in two ways: selective enhancement of activated PP2A to form holoenzyme would minimize formation of inactive holoenzymes, and efficient conversion of activated PP2A into substrate-specific holoenzymes would prevent uncontrolled phosphatase activity. In light of the role of Mutations to residues that either contact the PP2A active site or bind the PP2A tail, as well as mutations to catalytic residues, abolished the methyltransferase activity of LCMT-1. (E) ITC measuring the binding affinity of the PP2A core enzyme to LCMT-1 and LCMT-1 T29V. T29V mutation increases the binding affinity by 4-fold. Note that PP2A-LMCT-1 interaction is endothermic. (F) The conformation of the LCMT-1 active-site pocket changes considerably to allow binding of the PP2A tail. Based on structural alignment, the PP2A tail overlaps with the LCMT-1 apo structure (the one most similar to the complex is shown). The PP2A tail is shown in cylinder and the rest of the model in surface. See also Figure S2 and Table S1. LCMT-1 and PP2A methylation in the cell cycle (Lee and Pallas, 2007; Longin et al., 2007) , this provides a mechanism for LCMT-1 to integrate various signals for controlling cell-cycle progression.
LCMT-1 Dominant-Negative Mutant Attenuates Glioma Cell Proliferation after Stress
Defect of LCMT-1 T29V in PP2A methylation without affecting PP2A binding ( Figures 4C-4E ) indicated that T29V is a dominant-negative mutant. To test whether it mimics the phenotype of LCMT-1 knockdown, we transfected human LCMT-1 T29V into C6, a mouse glioma cell line, using a retrovirus vector. Wild-type LCMT-1 and a loss-of-function mutant, F237D, were Figure S3 and Table S1. used as controls. Recombinant LCMT-1 and its mutants were expressed as V5-tagged proteins, and their expression level was determined by western blot with anti-V5 antibody ( Figure 6A ). The level of PP2A methylation was determined by western blot with an antibody that specifically recognizes the unmethylated PP2A prior to and after the methyl group was removed by NaOH treatment ( Figure 6A ). We showed that after the cells underwent nutritional stress by culturing consecutively for 6 days without changing medium, C6 cells that stably express human LCMT-1 T29V reduced PP2A methylation without affecting the level of endogenous rat LCMT-1, whereas cells that express wild-type human LCMT-1 or the loss-of-function LCMT-1 mutant, F237D, exhibited little effect on PP2A methylation ( Figure 6A ). These data showed that T29V has dominant-negative effect on PP2A methylation.
Knockdown of LCMT-1 was previously shown to affect both cell-cycle progression and survival of HeLa and colon cancer cells (Lee and Pallas, 2007; Longin et al., 2007) . We showed that stable expression of human LCMT-1 T29V in C6 glioma cells did not cause significant cell death ( Figure 6B) ; trypan blue staining barely detected any dead cells (data not shown). After nutritional stress as described above, C6 cells expressing LCMT-1 T29V had a lower ratio of proliferating cells than control cells ( Figure 6B ). Consistently, C6 cells expressing LCMT-1 T29V showed a slower rate of increase in the cell number ( Figure 6C ). In contrast, expression of human LCMT-1 wild-type or loss of function mutant, F237D, in C6 glioma cells exhibited little effect on cell division or cell doubling rate under the same condition ( Figure 6B, 6C) . Similar results were obtained from viable cell assay ( Figure 6D ).
The ability of LCMT-1 T29V to attenuate the proliferation rate of glioma cells without causing cell death is different from the (H) The effect of PP2A phosphatase activity on cell fitness. The phosphatase activity of free C or the core enzyme is less controlled and might be detrimental to the cell; substrate-specific phosphatase activity of holoenzymes is essential for proper cellular function. Normal cells expressing WT LCMT-1 facilitate efficient transition of activated PP2A to holoenzymes, thus minimizing uncontrolled phosphatase activity. The effect of LCMT-1 knockdown or expression of LCMT-1 T29V is illustrated. For (C), (D), and (F), representative results of three independent experiments are shown. Data values are the average of three (C and D) and two (F) independent assays, respectively. Error bars represent the standard deviation. See also Figure S4 .
phenotype of LCMT-1 knockdown reported previously (Lee and Pallas, 2007; Longin et al., 2007) . To prove that LCMT-1 knockdown did indeed give different phenotypes than expression of LCMT-1 T29V, we knocked down the endogenous rat LCMT-1 by small interfering RNA (siRNA). Cell death was observed when the cellular LCMT-1 was diminished ( Figure 6E ). As illustrated in Figure 6H , we reasoned that LCMT-1 knockdown would unleash the uncontrolled phosphatase activity of free C or core enzyme and lead to cell death due to reduced methylation and holoenzyme assembly; expression of LCMT-1 T29V probably blocks the uncontrolled phosphatase activity, although methylation and holoenzyme assembly were reduced. Indeed, purified LCMT-1 T29V inhibited the phosphatase activity of the core enzyme with an efficacy 4-fold higher than that of wild-type LCMT-1 ( Figure 6F ), which agrees well with its 4-fold higher binding affinity ( Figure 4E ). This inhibition selectively targets the core enzyme or free C but not holoenzymes ( Figure S4A ), because LCMT-1 overlaps with regulatory subunits based on structural alignment of the PP2A-LCMT-1 complex and the B 0 holoenzyme ( Figure 6G ). Since holoenzyme assembly is essential for proper cellular function and cell-cycle progression, decrease in methylation, holoenzyme assembly, and uncontrolled phosphatase activity by LCMT-1 T29V attenuated cellcycle progression without causing cell death ( Figure 6H ).
DISCUSSION
PP2A is the most abundant protein phosphatase in all eukaryotic cells, and methylation is critical for the proper biogenesis and function of numerous PP2A holoenzymes. Despite its essential cellular function, the structural and biochemical basis of LCMT-1 function remained elusive. Using a synthetic SAM analog to trap the enzymatic intermediate, we crystallized the PP2A-LCMT-1 complex and elucidated the structural basis for the interaction between LCMT-1 and PP2A catalytic subunit and the enzymatic mechanism of LCMT-1. The structure of the complex provided unambiguous proof that LCMT-1 binds directly to the PP2A active site. We further demonstrated that PP2A methylation is highly sensitive to regulation of the phosphatase activity. This provides a structural and biochemical basis for LCMT-1 to integrate numerous signals that regulate the level of PP2A phosphatase activity for precise control of PP2A methylation. In light of complex regulations of the malleable PP2A active site in cells, the significance of this checkpoint function of LCMT-1 in PP2A methylation is two-fold: it (1) ensures assembly of functional PP2A holoenzymes and prevents formation of dominant-negative inactive holoenzymes and (2) facilitates efficient transition of the activated PP2A to substrate-specific holoenzymes, thus preventing the uncontrolled phosphatase activity of the PP2A core enzyme or free C subunit. The different consequences of LCMT-1 knockdown versus expression of a dominant-negative LCMT-1 mutant in glioma cells reflect the role of LCMT-1 in minimizing the unregulated activity of the PP2A core enzyme or free C. The ability of the LCMT-1 dominant-negative mutant to hamper cell-cycle progression without causing cell death probably relies on its ability to block the uncontrolled phosphatase activity of PP2A ( Figure 6F and Figures S4A and S4B ). Reduced PP2A holoenzyme formation, caused by reduced methylation (Figure 6A ), probably contributes to the attenuated cell cycle. It remains to be determined whether inactive holoenzymes are formed and contribute to the functional defects under LCMT-1 knockdown. Furthermore, it cannot be excluded that cell death caused by LCMT-1 knockdown is due to the combined effects of reduced holoenzyme formation and increase in the uncontrolled phosphatase activity.
Previous studies showed that PP2A methylesterase (PME-1) blocks methylation of inactive PP2A in yeast (Hombauer et al., 2007) . It is conceivable that LCMT-1, PME-1, and PTPA work in a concerted manner to control PP2A activation, methylation, and binding of regulatory subunits to the core enzyme in strictly ordered consecutive steps to ensure proper biogenesis of functional PP2A holoenzymes and minimize ambiguous PP2A function. Uncontrolled phosphatase activity and inactive holoenzymes are likely detrimental to cell survival and proper cellular functions ( Figure 6H) . Together, these studies demonstrated that, despite the huge complexity, different aspects of PP2A regulation and function are precisely controlled and coordinated, an emerging concept important for understanding PP2A function and its role in cellular signaling (Virshup and Shenolikar, 2009 ).
The level of PP2A methylation was previously shown to vary during the cell cycle (Turowski et al., 1995) , indicating that cellcycle regulators might participate in the regulation of PP2A methylation. While this can be modulated by the cellular level of LCMT-1 and PME-1, this manuscript revealed another mechanism for regulating PP2A methylation by alteration of the PP2A active site. Because of the highly regulated nature of the PP2A active site, PP2A methylation might represent a signaling ''hub'' that integrates various signals for controlling the cell cycle and likely other aspects of cellular functions. Modulation of PP2A activity and LCMT-1 function provides a potential strategy to control the cell cycle and survival of cancer cells. The structure of the PP2A-LCMT-1 complex provides an important basis for further investigation of the cellular function of LCMT-1 and PP2A methylation in PP2A holoenzyme biogenesis and in the cell cycle and cell survival.
EXPERIMENTAL PROCEDURES
Synthesis of SAM Analog
Synthesis of the SAM analog is carried out in three steps, as reported previously (Weller and Rajski, 2006) . In brief, first, the 5 0 hydroxyl group of adenosine was converted to a 5 0 hydroxylethylamino group after the Mitsunobu condensation reaction with o-NBS-protected a amino esters. Second, the aldehyde group of the protected g-aldehyde a amino acid was converged to the amino group of the 5 0 hydroxylethylamino adenosine obtained from the previous step; the resulting crosslink became stabilized after reduction. The aldehyde was produced from aspartate after the Rapoport sequence of thioester formation and reduction. Finally, iodination and deprotection led to the final product.
Protein Preparation
All constructs and point mutations were generated via a standard PCR-based cloning strategy. and missense mutants were cloned in pET15b (Invitrogen) and overexpressed at 37 C in E. coli BL21(DE3).
N-terminal truncation (d19) improved LCMT-1 solubility with no loss of enzyme activity (data not shown). For convenience, LCMT-1d19 is referred to as LCMT-1. The soluble fraction of E.coli cell lysate was purified over Ni-NTA
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Structural Insights into PP2A Methylation (QIAGEN) , further fractionated by cation exchange chromatography (Source 15S, Amersham) after removal of His 6 -tag. Cloning, expression, and purification of human PP2A A(a), C(a) subunits or mutants, and assembly of PP2A A-C core dimer was described previously . Note that full-length C (a) was used for functional studies.
The stable PP2A-LCMT-1 complexes were assembled by mixing of the PP2A core enzyme or the C subunit with LCMT-1 and SAM analog at 1:2:10 molar ratio, incubated at 30 C for 1 hr, and purified by anion exchange chromatography (Source 15Q, Amersham) and gel filtration chromatography (Superdex200, Amersham). Due to the difficulty of PP2A methylation in vitro, an excess amount of LCMT-1 was used to improve the level of covalent crosslink of PP2A to SAM analog.
Crystallization and Data Collection
Crystals of LCMT-1 bound to SAH were grown at 4 C via the hanging-drop vapor-diffusion method by mixing of the LCMT-1-SAH complex (10 mg/ml LCMT-1, 5 mM SAH) with an equal volume of reservoir solution containing 17%-19% PEG2000 monomethyl ether (v/v), 150 mM triethylamine N-oxide, and 5 mM DTT. The crystals are in space group P1, with unit cells containing either four molecules or eight molecules in each asymmetric unit. Crystals were equilibrated in a reservoir buffer with 20% glycerol (v/v) and flash frozen in liquid nitrogen. Native data sets were collected at NSLS beamline X25 and processed with the software DENZO and SCALEPACK (Otwinowski and Minor, 1997) . Crystals of the PP2Ac(d294-298)-LCMT-1 complex were grown at 18 C via the sitting-drop vapor-diffusion method by mixing of the complex (5 mg/ml) with an equal volume of reservoir solution containing 100 mM Tris (pH 8.2), 22%-26% PEG4000 (v/v), 200 mM sodium acetate, and 5 mM DTT. Diffracting crystals were generated by microseeding. The crystals were flash frozen as described above. The native data sets for the PP2Ac-LCMT-1 complex were collected at APS LS-CAT and processed with the software HKL2000 (Otwinowski and Minor, 1997).
Structure Determination
Using the dataset with four molecules of LCMT-1 per asymmetric unit, the structure of the LCMT-1-SAH complex was solved by molecular replacement with PHASER (McCoy et al., 2005) , and the coordinates of the yeast homolog PPM1 (accession code 1RFG) with nonconserved loop regions were removed. The electron density map was improved by noncrystallographic symmetry (NCS) averaging with AVE (Kleywegt and Read, 1997) . The structure was examined and modified with Coot (Emsley and Cowtan, 2004) and O (Jones et al., 1991) and refined using CNS with NCS restraints (Brü nger et al., 1998) to 2.2 Å . This structure was used for molecular replacement on the data set with larger unit cell; eight molecules were found in the asymmetric unit. The structure was built and refined by REFMAC (Murshudov et al., 1997 ) to 1.9 Å . The structure of the PP2A-LCMT-1 complex was solved by molecular replacement with two models, LCMT-1 and the C subunit (residues 6-293) from the structure of the PP2A core enzyme (accession code 2IE3), and one complex per asymmetric unit was found. The structure was built with Coot (Emsley and Cowtan, 2004) and refined with REFMAC restraints with TLS (Winn et al., 2003) and weights adjusted on the basis of R free . The PP2A tail was built after the electron density map was improved. The SAM analog was built with Sybyl (Tripos), and the topology file was generated with Dundee (Schü ttelkopf and van Aalten, 2004 ) for REFMAC refinement. Two TLS groups were used: (1) the C subunit (1-293) and (2) LCMT-1 together with the SAM analog and the last six residues of the PP2A tail. The structure was refined to 2.7 Å .
GST-Mediated Pulldown Assay
The pulldown assay was performed according to a previously described procedure . In brief, LCMT-1 or LCMT-1 mutants (10 mg in 100 ml binding buffer) were mixed with 20 ml glutathione resin with immobilized GST-tagged PP2A A-C dimer (10 mg) in the presence of 1 mg/ml BSA. The protein bound to resin was separated from unbound protein and analyzed by SDS-PAGE gels and Coomassie blue staining.
Methylation Assay
Methylation assays were performed by mixing of LCMT-1 (4-10 nM), PP2A (10-100 nM), and [ 3 H]-SAM (3 mM) in a reaction buffer containing 50 mM MOPS (pH 7.2), 20 mM DTT (omitted for oxidized PP2A), and 50 mM MnCl 2 (omitted for PPi-treated PP2A). After incubation at 37 C for 2-20 min, the reactions were stopped and precipitated by addition of 25% ice-cold trichloroacetic acid and 1 mg/ml BSA. The radioactivity of precipitate was quantified by scintillation counting. The results were used to estimate the rate of methylation. For dot blot, the indicated amount of PP2A core enzyme before and after in vitro methylation by LCMT-1 was spotted onto PVDF membrane and blotted by an antibody that specifically recognizes the unmethylated PP2A tail to determine the level of PP2A methylation (Millipore, clone 4b7).
Isothermal Titration Calorimetry
Binding affinities were measured by ITC. In brief, 15 mM PP2A core enzyme was titrated with 300 mM LCMT-1 or LCMT-1 T29V with a VP-ITC microcalorimeter (MicroCal). All proteins were prepared in a buffer containing 20 mM Tris (pH 7.5), 50 mM NaCl, and 50 mM MnCl 2 . The data were fitted by Origin 7.0.
Mammalian Cell Culture and Western Blot
The rat glioma cell line C6 was kindly provided by Andreas Friedl (University of Wisconsin at Madison). The cell was cultured in DMEM containing 1% FBS. V5-tagged human LCMT-1 or mutants were cloned into a retroviral vector harboring a GFP marker. The same titer of retroviruses packaged with LCMT-1 expression vectors or the empty vector were used to infect C6 culture with 50%-80% confluence. Infection efficiency was monitored by GFP marker, and expression of recombinant proteins was monitored by western blot against V5 tag. Knockdown of endogenous LCMT-1 was mediated by transfection of rat LCMT-1 siRNAs: CAGAAUGCCGAUGUCAAAU, CACUCCU GAUAACCGAAUG, and GAAGGAGAUAACCUAUUGA. Retrovirus-infected cells or cells transfected with siRNAs were collected after 48 hr. Cell extracts were examined by western blots with antibodies that specifically recognize the unmethylated C subunit of PP2A (Millipore, clone 4b7), the V5 tag (Millipore), the rat LCMT-1 (Santa Cruz Biotechnology, 4A4), and the loading control GADPH (Santa Cruz Biotechnology, A3) or actin (Millipore, clone C4), respectively. The total C subunit of PP2A was determined by antibody 4b7 after treatment with 0.1 N NaOH for 10 min at room temperature and neutralized by equal molar amount of HCl, similar to previously described (Favre et al., 1994) .
Cell Proliferation and Viability Assay
After nutritional stress, the same number of C6 cells infected by retroviruses packaged with LCMT-1 expression vectors or empty vectors were placed into 24-well and 96-well plates, respectively, and cultured in DMEM containing 1% FBS. Cell numbers of the 24-well cultures in triplicates were counted after trypsin digestion at the indicated culture time with and without trypan blue staining. The growth of viable cells was determined with the CellTiter-Glo luminescent cell viability assay (Promega) at the indicated culture time. The experiments were performed in triplicate and repeated three times. Values were normalized to the starting culture.
Phosphatase Assays PP2A phosphatase activity was measured with a Ser/Thr Phosphatase Assay Kit 1 (Upstate Biotechnology) according to manufacturer's instructions. Two microliters of 1 mM phosphopeptide substrate (K-R-pT-I-R-R) was added to 20 ml of PP2A sample (40-100 nM). The reaction was carried out at 30 C for 15 min and stopped by the addition of 50 ml malachite green solution. The absorbance at 620 nm was measured after 10 min incubation at room temperature.
Activation, Inhibition, Inactivation, and Oxidation of PP2A Free C or the core enzyme of PP2A was mixed with PTPA at a 1:1 molar ratio with C2 ceramide (N-Acetyl-D-sphingosine, Sigma) or synthetic peptide (KRTIRR) at the indicated concentration and incubated at 37 C for 5 min for PP2A activation. Okadaic acid was added to the core enzyme at a 2:1 molar ratio for PP2A inhibition. The PP2A core enzyme (1 mg/ml) was incubated at 37 C with 1 mM PPi for 50 min for inactivation and, after desalting, was diluted 100-fold into buffer containing 25 mM Tris (pH 8.0), 150 mM NaCl, and 20 mM DTT for phosphatase activity and methylation assay. The PP2A core enzyme was changed to DTT-free buffer by gel filtration chromatography to remove DTT (superdex 200, Amersham); the peak fraction (1.5 mg/ml) was incubated with 20 mM H 2 O 2 at 37 C for 30 min and, after desalting, was diluted at least 100-fold into reaction buffer containing 25 mM Tris (pH 8.0), 150 mM NaCl, and 50 mM MnCl 2 for the phosphatase activity and methylation assay. Phosphatase activity and methylation assay were performed as described above. All assays were performed in duplicate and repeated three times. Average values and standard error were calculated. Where indicated, values were normalized to the positive control.
ACCESSION NUMBERS
The atomic coordinates of LCMT-1-SAH and PP2A-LCMT-1 complexes were deposited in the Protein Data Bank under accession codes 3IEI and 3P71, respectively. 
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